Skip to main content
. 2010 Jul 14;9:7. doi: 10.4103/1477-3163.65448

Figure 5c-d.

Figure 5c-d

Cotreatment with dasatinib and JSI-124 synergistically inhibits growth and induces apoptosis of glioma cells. (c). The relationship between JSI-124 and dasatinib concentration and astrocyte cell numbers was assessed by MTS assay. (d) U87 cells were treated with dasatinib (100 nM), JSI-124 (200 nM) or the combination of both for 2 days. FACS analysis was performed as described in Materials and Methods